TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells. (Q40453338)

20 September 2017

TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells. (English)

1 reference

20 September 2017

Serena Vannucchi

1

1 reference

20 September 2017

Maria V Chiantore

2

1 reference

20 September 2017

Gianna Fiorucci

3

1 reference

20 September 2017

Zulema A Percario

4

1 reference

20 September 2017

Stefano Leone

5

1 reference

20 September 2017

Elisabetta Affabris

6

1 reference

20 September 2017

Giovanna Romeo

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

20 September 2017

1 reference

20 September 2017

24

1 reference

20 September 2017

2536-2546

1 reference

20 September 2017

15

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208403

20 September 2017

0 references

cites work

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

Second-generation interferons for cancer: clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

Genomic organization and transcriptional regulation of human Apo2/TRAIL gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

Pro-caspase-3 is a major physiologic target of caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

Isolation and molecular characterization of the 5'-upstream region of the human TRAIL gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

7 January 2021

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

7 January 2021

IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

7 January 2021

Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

7 January 2021

Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

7 January 2021

Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

7 January 2021

Cell cycle and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

7 January 2021

Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

7 January 2021

Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

7 January 2021

Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

7 January 2021

Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208403

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208403

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference